# Metformin as an Upstream Therapy in Atrial Fibrillation

> **NCT02931253** · PHASE2 · TERMINATED · sponsor: **The Guthrie Clinic** · enrollment: 6 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02931253
- **Lead sponsor:** The Guthrie Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-11
- **Primary completion:** 2018-07-10
- **Final completion:** 2018-07-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Recruitment issue: Enrollment expectation not met
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02931253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02931253, "Metformin as an Upstream Therapy in Atrial Fibrillation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02931253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*